Michael Obert joined the IR2Dx Canada Board of Directors in 2010. He recently retired as a partner at Dentons, an international legal practice. Prior thereto he served as Chief Legal Officer, SVP Corporate Development and a member of the Executive Leadership Team of a publicly traded life sciences company. Mr. Obert has extensive senior legal and business experience, both domestically and internationally, in the corporate-commercial, technology/IP and life sciences areas. He has worked on major collaboration, joint venture, M&A, technology licensing, public and private financing, and other similar transactions. He currently serves on a number of boards of technology/life science and non-profit organizations.